Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Bionor Pharma ASA - Disclosure of Shareholding

Bionor Pharma ASA
Posted on: 05 Oct 16

 
· Ferncliff Listed Dai AS, 270,000,000 shares representing 19.49% of the issued shares and votes in Bionor following completion of the rights issue
· Datum AS, 90,879,310 shares representing 6.56 % of the issued shares and votes  in Bionor following completion of the rights issue
· Cipriano AS, 50,000,000 shares representing 3.61 % of the issued shares and votes  in Bionor following completion of the rights issue
 
Ferncliff Listed Dai AS is controlled by Øystein Stray Spetalen and Cipriano AS is controlled by Einar J. Greve.
 
None of the shareholders above or their respective related persons hold any other shares or rights to shares in Bionor.
 
This information is subject to the disclosure requirements set out in section 4-3 of the Norwegian Securities Trading Act.

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Bionor Pharma ASA via GlobeNewswire
HUG#2047006
GlobeNewswire
globenewswire.com

Last updated on: 06/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.